1. Penn I, Hammond W, Brettschneider L, Starzl TE. Malignant lymphomas in transplantation patents. Transplant Proc 1969;1(1):106–112
2. Levy M, Backman L, Husberg B, et al. De novo malignancy following liver transplantation: a single-center study. Transplant Proc 1993;25(1 Pt 2):1397–1399
3. Nalesnik MA, Jaffe R, Starzl TE, et al. The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol 1988;133(1):173–192
4. Stieber AO, Boillot O, Scotti-Foglieni C, et al. The surgical implications of the posttransplant lymphoproliferative disorders. Transplant Proc 1991;23(1 Pt 2):1477–1479
5. Malatack JF, Gartner JC Jr, Urbach AH, Zitelli BJ. Orthotopic liver transplantation, Epstein–Barr virus, cyclosporine, and lymphoproliferative disease: a growing concern. J Pediatr 1991;118(5):667–675